Full-text resources of PSJD and other databases are now available in the new Library of Science.
Visit https://bibliotekanauki.pl
Preferences help
Polish version English version Language
enabled [disable] Abstract
Number of results

Results found: 4

Number of results on page
first rewind previous Page / 1 next fast forward last

Search results

Search:
in the keywords:  CRP
help Sort By:

help Limit search:
first rewind previous Page / 1 next fast forward last
1
Content available remote

Study of the Correlation between the Level of CRP and Chemerin of Serum and the Occurrence and Development of DN

100%
Wang Y., Wang M., Chen B., Shi J.
Open Medicine
|
2014
|
vol. 10
|
issue 1
EN
The aim of the study was to find the correlation between CRP and chemerin in development of DN. We choose 90 type-2 diabetic patients between February 2010 and February 2013, who were then divided into DN group and healthy control group. The results of BP showed that there is no difference in SBP and DBP of patients in the three groups. HDL-C of patients in diabetic group and DN group is lower compared with control. CRP in diabetic group and DN group is higher than that of patients in control group. Comparing the patients in DN group with that in diabeteic group, CRP was significantly higher. Chemerin level in the diabetic group and DN group is higher than control group. When comparing the patients in DN group with those in diabeteic group, serum level of chemerin was significantly higher. Serum level of chemerin is negatively correlated with HDL-C and positively correlated with FPG, HbA1c, LDL-C, BUN and Scr. Serum CRP is negatively correlated with HDL-C and positively correlated with FPG, HbA1c, LDL-C, BUN and Scr. Serum level of chemerin is positively correlated with CRP (r=0.701, P<0.05). CRP and chemerin of the DN patients rose significantly, and may participate in the occurrence and development of DN.
2
Content available remote

Can CRP affect the blood-brain barrier during acute ischemic stroke?

100%
Bielewicz J., Kurzepa J., Czekajska-Chehab E., Kamieniak P., Daniluk B., Bartosik-Psujek H.
|
|
issue 2
99-102
EN
Introduction. Ischemic strokes (IS) are one of the main causes of death and disabilities around the globe. Therefore, there is a huge need for researching the pathogenesis of IS. The C-reactive protein (CRP) plays a role during inflammatory processes. Results of some studies conducted on animal models indicate that CRP affects the blood-brain barrier (BBB) stability during IS. The presence of S100BB protein can be considered as an indication of BBB injury. Aim. The purpose of this study was to discover the relationship between CRP and S100BB protein. Material and methods. The study looked at fifty four IS patients, with the disease confirmed by computer tomography (CT). The clinical status was evaluated on the 1st, 3rd, 5th, 10th day and 3 months following the onset of IS. Neurological status was estimated using the National Institute of Health Stroke Scale (NIHSS). Patients’ disability level was determined, using Modified Rankin Scale (mRS) and Barthel Index (BI). The volume of ischemic focus was calculated on the 10th day after the stroke, using CT. The levels of CRP and S100BB were evaluated on 1st, 3rd, 5th and 10th day after the stroke onset with usage of ELISA method. Results. The mean level of CRP and its concentration on the 1st, 3rd, 5th and 10th day directly correlates with a deteriorated clinical status, as measured with the use of NIHSS, BI and mRS on day 10 and 3 months after the onset of IS. We found a correlation with the mean CRP level and bigger volume of ischemic injury. The mean CRP level correlated with the mean level of S100BB protein. In the group of patients with low CRP (0.51-24.68 mg/mL) the level of S100BB and the volume of ischemic focus were lower than in the group with a high level of CRP (24.69-209 mg/mL). Conclusions. CRP can be considered as a predictor of a worse clinical outcome after stroke. The relationship between CRP and S100BB protein can suggest the active role of CRP during IS
3
Content available remote

Effect of perioperative glutamine administration on C-reactive protein and liver function tests in patients undergoing hepatic resection

100%
Richard V., Dahiya D., Kaman L., Raj P., Behera A.
|
|
vol. 86
|
issue 1
11-16
EN
Hepatic resections are commonly associated with high morbidity and mortality. Nutrition plays an important role in reducing postoperative complications besides improvement in intensive care and perioperative management. The aim of the study was to evaluate the role of glutamine as an immunonutrient in patients undergoing hepatic resection. Material and methods. The study included 22 patients who underwent hepatectomy. Patients were randomized into two equal groups wherein group A patients received perioperative glutamine whereas group B patients served as controls. Primary outcome measures were level of serum albumin, C‑reactive protein (CRP), liver function tests and absolute neutrophil counts in the postoperative period while secondary outcome included post operative complications. Results. Glutamine decreased the CRP response in liver resection in a statistically significant manner (p=0.028) on the fifth post operative day. This may signify that glutamine decreases the post operative inflammatory response associated with liver resection. Glutamine did not have any significant effect on liver function tests. Postoperative morbidity was less in patients who received glutamine. Conclusion. Glutamine successfully blunted the CRP response in patients who received glutamine postoperatively. Decrease in morbidity following glutamine administration is an attractive area of prospective research and requires further consideration involving larger patient groups.
4
Publication available in full text mode
Content available

Analiza porównawcza wyników oznaczeń laboratoryjnych biomarkerów zapalenia – wskaźnika sedymentacji krwinek czerwonych (ESR) i białka C-reaktywnego (CRP) w stanach zapalnych u pacjentów hospitalizowanych

100%
Siudzińska A., Łobos M., Sujecki A., Paradowski M., Łobos M.
|
|
vol. 40
|
issue 2
207-233
EN
Introduction: Erythrocyte sedimentation rate (ESR, in Poland known as OB) and C-reactive protein (CRP) are biomarkers most often used to diagnose and monitor systemic inflammation. However, they are independent markers and have different properties. The aim of this study was to compare the values of specific markers of systemic inflammation such as ESR and CRP in patients hospitalized in the internal wards and suspected of suffering from systemic inflammation. Material and methods: The study group included 187 patients (99 women and 88 men, aged from 20 to 97 years) hospitalized in the internal medicine clinics of the Military Medical Academy University Teaching Hospital - Central Veterans' Hospital in Lodz. Each marker of inflammation, ESR and CRP, were measured in patients’ peripheral blood (ESR) and serum (CRP). Results: For the diagnosis of inflammation there was no significant correlation between CRP and ESR in groups of patients both with mild (CRP > 6.1 – 40 mg/L) and severe (CRP ≥ 40.1) inflammation. However, in persons with highly developed inflammation (ESR ≥ 31 mm/h and CRP ≥ 40.1 mg/L) there was a strong correlation between the mentioned biomarkers (r = 0.9973). Conclusions: The results indicate that CRP and ESR biomarkers are independent parameters that are clinically useful for the diagnosis and monitoring of inflammations. For the diagnosis of acute inflammation the designation of serum CRP is clinically more useful than the measurement of ESR.
PL
Wstęp: Odczyn opadania krwinek czerwonych (ESR, w Polsce znany pod nazwą odczyn Biernackiego - OB) i stężenie białka C-reaktywnego (CRP) są najczęściej wykorzystywanymi przez lekarzy biomarkerami do rozpoznawania i monitorowania stanu zapalnego ustroju. Jednak są one wskaźnikami niezależnymi i cechują się różnymi własnościami. Celem niniejszej pracy była analiza porównawcza wyników oznaczeń dwóch laboratoryjnych biomarkerów zapalenia: ESR i CRP u pacjentów leczonych na oddziałach internistycznych, u których podejrzewano narastający lub istniejący proces zapalny. Materiał i metody: Badaniem objęto 187 chorych (99 kobiet i 88 mężczyzn, w wieku od 20 do 97 lat) hospitalizowanych w klinikach chorób wewnętrznych Uniwersyteckiego Szpitala Klinicznego im. Wojskowej Akademii Medycznej – Centralnego Szpitala Weteranów w Łodzi. U każdego pacjenta w tym samym czasie wykonano oznaczenie dwóch wskaźników stanu zapalnego: ESR i CRP. Wyniki: Dla rozpoznawania narastającego zapalenia nie wykazano istotnej korelacji między CRP i ESR w grupach pacjentów zarówno o małym (CRP > 6,1 – 40 mg/L), jak i dużym (CRP ≥ 40,1) nasileniu zapalenia. Z drugiej strony, u ludzi z silnie już rozwiniętym zapaleniem (ESR ≥ 31 mm/h i CRP ≥ 40,1 mg/L) zaznaczyła się wysoka korelacja pomiędzy tymi biomarkerami (r = 0,9973). Wnioski: Wyniki wskazują, że analizowane biomarkery CRP i ESR są parametrami niezależnymi i są klinicznie użyteczne w rozpoznawaniu i obserwacji stanów zapalnych. W rozpoznawaniu zapalenia o ostrym przebiegu bardziej użytecznym klinicznie biomarkerem jest stężenie CRP w surowicy niż wartość ESR.
first rewind previous Page / 1 next fast forward last
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.